Vidachim AD Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	-0.01	-	-	-	-	-
Other Revenue	-	-	-	-	-	-0
Revenue	-0.01	-	-	-	-	-0
Cost of Revenue	0.06	0.01	0.01	0.02	0.01	0
Gross Profit	-0.07	-0.01	-0.01	-0.02	-0.01	-0
Selling, General & Admin	0.16	0.17	0.25	0.19	0.07	0.07
Other Operating Expenses	0.01	0.01	-0.01	0.03	0.01	0.01
Operating Expenses	0.17	0.19	0.24	0.22	0.09	0.08
Operating Income	-0.24	-0.19	-0.25	-0.24	-0.1	-0.08
Interest Expense	-0.03	-	-	-	-	-
Other Non Operating Income (Expenses)	-0.1	-0.1	-	-	-	-
EBT Excluding Unusual Items	-0.37	-0.29	-0.25	-0.24	-0.1	-0.08
Gain (Loss) on Sale of Assets	0.15	0.15	-	-	-	-
Legal Settlements	-0.15	-0.15	-	-	-	-
Other Unusual Items	-	-	-	-	0.01	-
Pretax Income	-0.37	-0.29	-0.25	-0.24	-0.09	-0.08
Net Income	-0.37	-0.29	-0.25	-0.24	-0.09	-0.08
Net Income to Common	-0.37	-0.29	-0.25	-0.24	-0.09	-0.08
Shares Outstanding (Basic)	-	3	3	3	3	3
Shares Outstanding (Diluted)	-	3	3	3	3	3
EPS (Basic)	-	-0.10	-0.09	-0.08	-0.03	-0.03
EPS (Diluted)	-	-0.10	-0.09	-0.08	-0.03	-0.03
Free Cash Flow	0.05	-0.01	-0.02	-0.03	0	-0.05
Free Cash Flow Per Share	-	-0.00	-0.01	-0.01	-	-0.02
EBITDA	-	0.54	-	-	-	-
D&A For EBITDA	-	0.73	-	-	-	-
EBIT	-0.24	-0.19	-0.25	-0.24	-0.1	-0.08
Revenue as Reported	0.17	0.17	0.05	0.01	0.01	0